Siriporn C Chattipakorn Selected Research

salicylhydroxamic acid (SHAM)

1/2023	Acute administration of myeloid differentiation factor 2 inhibitor and N-acetyl cysteine attenuate brain damage in rats with cardiac ischemia/reperfusion injury.
8/2022	An apoptosis inhibitor suppresses microglial and astrocytic activation after cardiac ischemia/reperfusion injury.
7/2022	Ischemic preconditioning upregulates Mitofusin2 and preserves muscle strength in tourniquet-induced ischemia/reperfusion.
10/2021	Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury.
10/2020	Metformin preferentially provides neuroprotection following cardiac ischemia/reperfusion in non-diabetic rats.
10/2020	A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats.
1/2019	Testosterone deprivation intensifies cognitive decline in obese male rats via glial hyperactivity, increased oxidative stress, and apoptosis in both hippocampus and cortex.
1/2019	N-acetylcysteine with low-dose estrogen reduces cardiac ischemia-reperfusion injury.
1/2019	Combined dipeptidyl peptidase-4 inhibitor with low-dose testosterone exerts greater efficacy than monotherapy on improving brain function in orchiectomized obese rats.
1/2016	Testosterone deprivation accelerates cardiac dysfunction in obese male rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siriporn C Chattipakorn Research Topics

Disease

82	Mitochondrial Diseases (Mitochondrial Disease) 02/2024 - 08/2012
56	Insulin Resistance 12/2022 - 03/2011
53	Inflammation (Inflammations) 01/2024 - 11/2015
43	Cognitive Dysfunction 04/2024 - 10/2014
37	Reperfusion Injury 10/2023 - 01/2015
35	Obesity 10/2023 - 01/2014
33	Iron Overload 03/2024 - 03/2013
30	Ischemia 01/2023 - 01/2015
25	Cardiotoxicity 04/2024 - 01/2020
24	Neoplasms (Cancer) 01/2024 - 02/2015
23	Infarction (Infarctions) 10/2023 - 05/2013
22	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 07/2013
21	Left Ventricular Dysfunction 10/2023 - 01/2015
17	Cardiac Arrhythmias (Arrythmia) 01/2023 - 01/2013
16	Cardiomyopathies (Cardiomyopathy) 11/2023 - 01/2015
14	Dysbiosis 05/2024 - 01/2017
14	Heart Failure 01/2024 - 01/2015
11	Myocardial Infarction 01/2024 - 01/2016
11	Thalassemia 02/2023 - 01/2015
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022 - 01/2015
11	Body Weight (Weight, Body) 01/2022 - 11/2011
10	Neuroinflammatory Diseases 04/2024 - 01/2021
10	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 03/2010
8	Heart Diseases (Heart Disease) 11/2023 - 01/2015
8	Myocardial Ischemia (Ischemic Heart Diseases) 10/2023 - 01/2015
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2012
6	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2020
6	Chemotherapy-Related Cognitive Impairment 04/2024 - 01/2020
6	Fibrosis (Cirrhosis) 03/2024 - 06/2015
6	Prediabetic State (Prediabetes) 10/2023 - 01/2020
6	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 01/2016
5	Osteoporosis 11/2023 - 10/2019
5	Pain (Aches) 02/2022 - 04/2018
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2013
4	Cardiomegaly (Heart Hypertrophy) 01/2024 - 01/2016
4	Infections 11/2023 - 10/2019
4	Brain Ischemia (Cerebral Ischemia) 04/2023 - 11/2020
4	Stroke (Strokes) 11/2020 - 01/2019
4	Hyperglycemia 01/2020 - 08/2017
3	Dyslipidemias (Dyslipidemia) 04/2024 - 11/2019
3	Anemia 02/2024 - 01/2017
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 10/2020

Drug/Important Bio-Agent (IBA)

47	Insulin (Novolin)FDA Link 12/2022 - 03/2011
29	IronIBA 11/2023 - 03/2013
28	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2016
27	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 01/2020
24	Metformin (Glucophage)FDA LinkGeneric 02/2023 - 08/2012
17	Estrogens (Estrogen)FDA Link 12/2022 - 11/2011
16	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 01/2015
16	VildagliptinIBA 01/2018 - 08/2012
15	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2017
13	Testosterone (Sustanon)FDA Link 12/2020 - 01/2015
12	AntioxidantsIBA 03/2024 - 01/2016
12	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2015
11	fibroblast growth factor 21IBA 02/2023 - 11/2015
11	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 08/2012
10	CalciumIBA 01/2024 - 01/2016
10	CytokinesIBA 11/2023 - 12/2014
10	MelatoninIBA 08/2023 - 11/2018
10	Chelating AgentsIBA 10/2022 - 01/2016
10	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 10/2014
9	Donepezil (Aricept)FDA LinkGeneric 05/2024 - 01/2021
9	Galactose (Galactopyranose)FDA LinkGeneric 12/2023 - 01/2018
9	LipidsIBA 10/2022 - 11/2015
8	Trastuzumab (Herceptin)FDA Link 11/2023 - 01/2020
7	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 10/2023 - 01/2018
7	DeferiproneIBA 02/2023 - 01/2016
7	Neuroprotective AgentsIBA 01/2023 - 01/2018
7	PrebioticsIBA 12/2020 - 01/2017
6	Indicators and Reagents (Reagents)IBA 11/2023 - 01/2015
6	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022 - 01/2017
6	humaninIBA 01/2022 - 01/2016
6	CholesterolIBA 06/2021 - 08/2012
6	Amyloid beta-PeptidesIBA 01/2021 - 07/2017
5	Cholinesterase Inhibitors (Anticholinesterases)IBA 04/2024 - 03/2010
5	Cysteine (L-Cysteine)FDA Link 01/2023 - 01/2016
5	Transferrin (beta 2 Transferrin)IBA 01/2022 - 08/2013
5	Atorvastatin (Lipitor)FDA Link 10/2020 - 01/2018
5	Insulin ReceptorIBA 01/2018 - 11/2011
4	necrostatin-1IBA 11/2023 - 01/2020
4	human ERBB2 proteinIBA 11/2023 - 04/2020
4	efonidipineIBA 02/2023 - 04/2016
4	Dacarbazine (DIC)FDA LinkGeneric 12/2022 - 11/2021
4	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 11/2015
4	Caspase 3 (Caspase-3)IBA 11/2022 - 05/2013
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 10/2017
4	Lipocalin-2IBA 01/2022 - 01/2018
4	Isoflurophate (DFP)FDA Link 03/2018 - 01/2016
3	Oxygen (Dioxygen)IBA 02/2024 - 01/2018
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2024 - 01/2021
3	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2020
3	Toll-Like Receptor 4IBA 01/2024 - 01/2022
3	LipopolysaccharidesIBA 01/2024 - 01/2022
3	Saline SolutionIBA 12/2023 - 10/2020

Therapy/Procedure

40	Therapeutics 01/2024 - 06/2014
15	Drug Therapy (Chemotherapy) 04/2024 - 02/2015
8	Vagus Nerve Stimulation 11/2023 - 10/2014
5	Caloric Restriction 12/2023 - 01/2019
5	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2017
4	Glycemic Control 01/2018 - 10/2015